Pharmaceutical companies that want to use influencers to promote their products should provide compliance training on US Food and Drug Administration promotional requirements, ensure the content conveys the typical patient experience in line with a drug’s labeling, and set expectations about the need for marketing, legal and regulatory review of content before posting.
Those are some of the rules of the road suggested by regulatory, advertising and legal experts at panel discussions on influencers and social media during the Drug Information
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?